
Biological sex is among the most defining traits influencing cellular radiation responses, yet the mechanisms underlying these differences remain poorly characterized. This is particularly true for high linear energy transfer (LET) exposures relevant to deep space travel. Interactions between galactic cosmic radiation and spaceflight hardware can propagate secondary neutrons, a major component of the space radiation risk associated with human travel to the moon and Mars. Radiation-induced damage to the human bone marrow (BM) is a specific concern in space travel, as injury to sensitive hematopoietic stem/progenitor cells (HSPCs) can trigger acute radiation syndrome. We investigated sex-dependent responses of primary human BM-derived HSPCs after exposure to 0.5 Gy of neutrons, modeling the high-LET contributions expected during a Mars-class mission. After radiation exposure, CD34+ HSPCs from male and female donors were cultured in suspension and analyzed by flow cytometry at 48 h, 1 week, and 2 weeks after exposure to capture both acute injury and the regenerative dynamics of the blood system. While acute (48 h) responses were comparable between males and females, male-derived HSPCs exhibited increased sensitivity over time, with a significant reduction in CD34+ progenitor frequencies at 1 week relative to female cells. In addition, cultures from males showed a sustained expansion of CD11b+ myeloid cells compared with untreated controls at both 1 and 2 weeks after irradiation, an effect that was subdued in female cells by week 2. These findings indicate that high-LET exposures may drive sexual dimorphism in HSPC maintenance and lineage commitment. Our study establishes biological sex as a critical factor in human blood and immune cell responses to neutron radiation and underscores the need to incorporate astronaut-specific considerations in countermeasure development for deep space exploration.
Preclinical FLASH animal studies have primarily employed large single doses of radiation. These results suggest that the FLASH normal tissue-sparing effect may most readily be observed in the context of radiosurgery and stereotactic body radiotherapy, whereas most clinical schedules employ small doses per fraction. The present study examines the impact of dose size, dose rate, and overall treatment time on the magnitude of the FLASH sparing effect in mouse skin. Mouse skin contraction was evaluated 55 days after 27 Gy irradiation, delivered at FLASH (127.5 ± 2.5 Gy/s for 0.213 s) and conventional dose rates (CDR, 0.5 ± 0.01 Gy/s for 54 s). In addition, we introduced time gaps in dose delivery. This approach was based on the hypothesis that oxygen depletion is the mechanism of FLASH tissue sparing, with the loss of tissue sparing corresponding to the time for tissue to reoxygenate. Tissue irradiated with proton spot scanning FLASH treatments may experience similar time structures. To evaluate the impact of dose per pulse size, we delivered 27 Gy in 2 pulses of 13.5 Gy, 4 pulses of 6.75 Gy and 8 pulses of 3.375 Gy over the same 54 s time frame to deliver 27 Gy conventional dose rate irradiation. For each of the beam pulses, the instantaneous FLASH dose rate was 127.5 ± 2.5 Gy/s. To evaluate the impact of longer time intervals that would occur, for example, between treatment fields, two FLASH pulses of 13.5 Gy/pulse were administered, each lasting 0.125 s and separated by up to 150 s. To measure skin contraction, two tattoo dots were placed ∼1 cm apart on the hind leg of each mouse. The legs were then irradiated with a 1.6 × 1.2 cm 2 elliptical beam covering the tattoos. The decrease in the distance between the dots was evaluated at four-day intervals from day 4 to day 20 and weekly thereafter. Delivering a dose of 27 Gy in 2, 4, or 8 equally spaced pulses over 54 s, which is the same as the CDR irradiation time for 27 Gy, resulted in no observed difference in the contraction fraction for any spacing. When a single 27 Gy FLASH dose was administered or the dose was delivered in two 13.5 Gy pulses separated by only 0.125 s, a tissue sparing effect was observed compared to CDR. However, the FLASH effect was no longer observed at pulse separations of 0.463 s or longer, corresponding to dose rates of 40 Gy/s or lower. Our data show that administration of two dose pulses of FLASH irradiation does not elicit a tissue-sparing effect when of 0.463 s or longer elapses between pulses. The results indicate that the FLASH effect depends on the total time required to deliver the total dose. This study does not prove oxygen depletion as the mechanism of the FLASH effect, but it is consistent with it, with tissue reoxygenation during a 0.463 s interval or longer between irradiation pulses resulting in a loss of the FLASH tissue effect.
Synchrotron-generated microbeam X-rays are emerging as a novel promising therapeutic strategy for the treatment of drug-resistant epilepsy. One important limiting factor of radiotherapy for the treatment of drug-resistant epilepsy, brain tumors and metastases is the onset of cognitive deficits and dementia due to the reduction of hippocampal neurogenesis. The long-term safety of synchrotron-generated X-ray microbeam irradiation is a concern for translating this novel irradiation technique to humans. Here we show the effects of synchrotron-generated X-ray microbeam irradiation of the dorsal hippocampus in healthy rats in the short-, mid- and long-term. Healthy rats were irradiated with either homogeneous broadbeams (10 Gy) or 2 arrays composed of 10 parallel microbeams each (75 μm wide, spaced 400 μm center-to-center, 300 or 600 Gy) in the cerebral cortex and the dorsal hippocampus. Rats underwent behavioral testing, histological and immunohistochemical analysis, and stereological counts of proliferating cells in the hippocampal dentate gyrus. X-ray microbeam irradiation delivering peak doses of 300 Gy reduced depressive-like behavior, and this antidepressant effect was associated with an increase of hippocampal dentate gyrus neurogenesis in the short-, mid- and long-term. Spontaneous locomotor activity, hippocampal-mediated cognition and microvessels were not affected by X-ray microbeam irradiation. These data shed light on the long-term radiobiology of microbeams in the central nervous system and lay the groundwork for their use in treating drug-resistant epilepsy and other neurological disorders associated with reduced neurogenesis.
With the increasing use of computed tomography, the biological effects of low-dose ionizing radiation (LDIR) have gained attention. However, its effects on B lymphocytes remain understudied. We investigated LDIR-induced oxidative stress in lymphocytes to establish a theoretical basis for clinical radiation safety. First, we demonstrated that LDIR induces a rapid oxidative response in the human B-lymphoblastoid cell line IM-9. Reactive oxygen species (ROS) levels increased at 0.25 h and decreased at 1 h after LDIR. In parallel, the number and intensity of γ-H2A.X and 53BP1 DNA damage foci significantly increased in the irradiated group. Transcriptome analysis identified Forkhead box protein O1 (FOXO1) as a key gene. Western blotting analysis showed that Sirtuin-1 (SIRT1) activity decreased at 0.25 h after irradiation, while the activity of FOXO1 and acetylated FOXO1 increased. Superoxide dismutase 2 (SOD2) activity decreased initially and then increased at 1 h. A co-immunoprecipitation (Co-IP) assay confirmed the interaction between FOXO1 and SIRT1, supporting their coordinated role in oxidative regulation. LDIR induced oxidative stress via the SIRT1/FOXO1 axis. These results demonstrate that early ROS accumulation suppresses SIRT1 activity, impedes FOXO1 deacetylation, and transiently reduces SOD2 activity, followed by a compensatory induction of SOD2 to restore redox balance.
As human space missions venture further beyond low Earth orbit, understanding the skeletal risks posed by prolonged exposure to the space environment becomes increasingly urgent. This review examines the effects of ionizing radiation on bone structure and homeostasis, focusing primarily on bone rather than bone marrow. While bone loss due to microgravity is well established, radiation-induced bone degeneration remains less thoroughly characterized. We compare space radiation with diagnostic and therapeutic exposures, highlighting key differences in dose rates, particle types, and biological outcomes. At the structural level, both low and high linear energy transfer (LET) radiation reduce trabecular bone volume, with high LET exposures causing more severe damage. At the cellular level, radiation disrupts osteoblast differentiation, promotes osteoclastogenesis, and induces apoptosis of osteocytes, leading to imbalanced bone remodeling. These effects are exacerbated when combined with mechanical unloading. Pharmacologic countermeasures such as parathyroid hormone (PTH), teriparatide, sclerostin-neutralizing antibody, and bisphosphonates, as well as antioxidant-rich diets, show promise in mitigating radiation-induced bone loss. However, most studies rely on acute, high-dose models that fail to replicate the chronic low-dose conditions of spaceflight. Future work should focus on osteocyte-specific responses, cellular proliferation after exposure to low dose high LET radiation, the long-term impact of chronic radiation, and how current countermeasures perform under realistic spaceflight conditions.